Expert Interview
Another View: Discussing Morphic's MORF-057 (oral a4b7 integrin) and its potential in ulcerative colitis ahead of the Phase 2a readout
Ticker(s): MORFInstitution: NYU Langone
- Medical Director for the Inflammatory Bowel Diseases (IBD) Program at NYU Langone Long Island.
- Manages 150 patients with ulcerative colitis.
- Co-authored several studies in inflammatory bowel disease; Practice encompasses all facets of general gastroenterology including gastroesophageal reflux disease (GERD), peptic ulcer disease, chronic constipation, ulcerative colitis and irritable bowel syndrome (IBS), with additional expertise in inflammatory bowel diseases.
Are You Interested In These Questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
